Solubilities of phenazopyridine, propranolol, and methimazole in supercritical carbon dioxide
- 15 February 2003
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 32 (1) , 181-187
- https://doi.org/10.1016/s0731-7085(03)00016-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Solubilities of Some Nitrogen-Containing Drugs in Supercritical Carbon DioxideJournal of Chemical & Engineering Data, 2001
- Solubilities of 5-Fluorouracil and β-Estradiol in Supercritical Carbon DioxideJournal of Chemical & Engineering Data, 2000
- Solubility of Polycyclic Aromatic Hydrocarbons in Supercritical Carbon DioxideJournal of Chemical & Engineering Data, 1999
- Solubilities of Some Hydroxyxanthone Derivatives in Supercritical Carbon DioxideJournal of Chemical & Engineering Data, 1999
- Solubilities of Some 1,4-Dihydroxy-9,10-anthraquinone Derivatives in Supercritical Carbon DioxideJournal of Chemical & Engineering Data, 1998
- Solubilities of Flavone and 3-Hydroxyflavone in Supercritical Carbon DioxideJournal of Chemical & Engineering Data, 1997
- Solubility Study of Sulfamethazine and Sulfadimethoxine in Supercritical Carbon Dioxide, Fluoroform, and Subcritical Freon 134AJournal of Chemical & Engineering Data, 1997
- Solubilities of the Fat-Soluble Vitamins A, D, E, and K in Supercritical Carbon DioxideJournal of Chemical & Engineering Data, 1997
- Solubility of Anti-Inflammatory Drugs in Supercritical Carbon DioxideJournal of Chemical & Engineering Data, 1996
- Solubility of Polycyclic Aromatic Hydrocarbons in Supercritical Carbon Dioxide from 313 K to 523 K and Pressures from 100 bar to 450 barJournal of Chemical & Engineering Data, 1996